论文部分内容阅读
目的分析盐酸氨溴索与布地奈德联合雾化吸入治疗支气管肺炎的临床疗效。方法本院根据随机对照、平行、单盲的原则,选取支气管肺炎患者84例为本研究对象,其中将采用布地奈德治疗的患者设为常规组,将采用盐酸氨溴索与布地奈德联合雾化吸入治疗的患者设为试验组,每组患者各42例。对两组患者的治疗效果进行比较分析。结果试验组患者治疗总有效率为95.24%(40/42);显著高于常规组88.10%(37/42);差异比较显著具备统计学意义。结论在对支气管肺炎患者进行治疗期间,运用盐酸氨溴索与布地奈德联合雾化吸入效果优于单纯采用布地奈德治疗,效果更为显著,值得推广使用。
Objective To analyze the clinical efficacy of ambroxol hydrochloride combined with budesonide in the treatment of bronchial pneumonia. Methods According to the randomized controlled, parallel and single-blind principle, 84 patients with bronchial pneumonia were selected as the research object. Among them, patients treated with budesonide were set as routine group, and ambroxol hydrochloride combined with budesonide Patients treated with nebulized inhalation were set as the test group, with 42 patients in each group. The treatment effect of two groups of patients were compared. Results The total effective rate of the trial group was 95.24% (40/42), significantly higher than that of the conventional group (88.10%, 37/42). The difference was statistically significant. Conclusions During the treatment of patients with bronchopneumonia, the combination of ambroxol hydrochloride and budesonide inhalation is better than budesonide alone, which is more effective and worthy of promotion.